Glaxo SmithKline Taking Soft Merger Route: Will Start With Two U.S. Heads
The U.S. pharmaceutical operations of Glaxo Wellcome and SmithKline Beecham will not be combined immediately as part of the merger integration process.
The U.S. pharmaceutical operations of Glaxo Wellcome and SmithKline Beecham will not be combined immediately as part of the merger integration process.